- Home
- IQV vs HUM Comparison
IQV vs HUM Comparison
Compare IQV & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- HUM
- Stock Information
- Founded
- IQV 1982
- HUM 1961
- Country
- IQV United States
- HUM United States
- Employees
- IQV N/A
- HUM N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- HUM Medical Specialities
- Sector
- IQV Health Care
- HUM Health Care
- Exchange
- IQV Nasdaq
- HUM Nasdaq
- Market Cap
- IQV 31.6B
- HUM 32.0B
- IPO Year
- IQV 2013
- HUM 1993
- Fundamental
- Price
- IQV $156.39
- HUM $259.65
- Analyst Decision
- IQV Strong Buy
- HUM Hold
- Analyst Count
- IQV 18
- HUM 21
- Target Price
- IQV $248.72
- HUM $289.05
- AVG Volume (30 Days)
- IQV 1.6M
- HUM 1.3M
- Earning Date
- IQV 05-01-2025
- HUM 04-30-2025
- Dividend Yield
- IQV N/A
- HUM 1.33%
- EPS Growth
- IQV 2.74
- HUM N/A
- EPS
- IQV 7.49
- HUM 9.98
- Revenue
- IQV $15,405,000,000.00
- HUM $117,761,000,000.00
- Revenue This Year
- IQV $4.25
- HUM $7.27
- Revenue Next Year
- IQV $6.17
- HUM $1.45
- P/E Ratio
- IQV $22.38
- HUM $26.60
- Revenue Growth
- IQV 2.81
- HUM 10.71
- 52 Week Low
- IQV $166.16
- HUM $213.31
- 52 Week High
- IQV $252.88
- HUM $406.46
- Technical
- Relative Strength Index (RSI)
- IQV 24.11
- HUM 42.53
- Support Level
- IQV $169.37
- HUM $261.00
- Resistance Level
- IQV $188.39
- HUM $274.93
- Average True Range (ATR)
- IQV 5.33
- HUM 7.01
- MACD
- IQV -1.74
- HUM -0.28
- Stochastic Oscillator
- IQV 2.23
- HUM 1.28
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.